Search

everythinglearnresearchcommunity

for

Search:↓

The user experienced significant hair regrowth after using minoxidil for 9 months and finasteride for 3 months, with plans to continue treatment and possibly get a hair transplant. Some users suggested adding microneedling and other treatments, while others discussed potential side effects of finasteride.

A 35-year-old man underwent a hair transplant with Dr. Patty at HairTran Clinic in Bangkok, receiving 4,037 grafts primarily for his crown area. The procedure cost 188,700 THB, with an additional 12,000 THB for optional PRP treatment, and he plans to update with progress pictures in a year.

Pelage plans to conduct two Phase 3 trials for PP405, a new hair loss treatment, which may take about a year to complete. Users discuss various hair loss treatments, including pyrilutamide, minoxidil, finasteride, and clascoterone, with some expressing impatience over the lengthy trial process compared to faster drug approvals like the COVID vaccine.

A 19-year-old is concerned about long-term microneedling for hair loss and is unsure if it will remain effective as they age. They experienced side effects from topical finasteride and are considering whether to try it again in the future, while also dealing with body dysmorphia and stress.

The user switched from finasteride to dutasteride, uses minoxidil twice daily, dermastamps weekly, and massages occasionally, showing significant hair improvement after one year. They noticed the biggest change after combining finasteride with minoxidil and have not experienced shedding since starting minoxidil.

The user is considering stopping finasteride after 1.8 years due to concerns about side effects and is exploring alternatives like minoxidil and topical finasteride. They are also considering microneedling and are advised to wait for new treatments like breezula/clascoterone.

The user has been using finasteride for 5 months along with minoxidil, microneedling, and keto shampoo but hasn't seen significant regrowth and is considering switching to dutasteride. Others advise patience, suggesting waiting at least a year to see results, as finasteride often takes time to show effects.

PP405 is a promising hair growth stimulant but not a cure for advanced hair loss, as it may only help dormant follicles. Treatments like Minoxidil, Finasteride, and Dutasteride are discussed, with emphasis on early intervention for effectiveness.

The conversation discusses hair loss treatments, specifically finasteride, minoxidil, ketoconazole shampoo, and microneedling, with users experiencing initial success followed by increased shedding and regression. Many users suggest patience, as hair cycles can take years, and some attribute changes to seasonal shedding.

Minoxidil is often applied once or twice daily for hair growth, but many find it inconvenient and switch to once daily or oral minoxidil for ease. Some users combine it with finasteride for better results, despite potential side effects.

A 20-year-old male using 1mg finasteride daily and 5% minoxidil twice a day for two months reported significant hair regrowth with no side effects. Users discussed the effectiveness of these treatments, the importance of consulting a doctor, and the potential for continued improvement over time.

Hair loss treatments like Minoxidil, finasteride, and RU58841, focusing on their effectiveness and side effects. It also highlights the disparity in medical research funding between hair loss and conditions like endometriosis.

Clascoterone (Breezula) shows a potential 500% increase in hair growth, possibly outperforming minoxidil and finasteride. It is in advanced trials, with hopes for FDA approval, but cost and side effects are concerns.

Oral minoxidil, finasteride, and dutasteride are being used to treat hair loss, but results are limited, leading to consideration of a hair transplant. The user plans to continue medication for another year before deciding on further action.

A 25-year-old male is experiencing hair thinning at the hairline and vertex, considering using a dermapen or dermastamp, and seeking advice on whether to continue with natural remedies like onion juice and rosemary oil or start using minoxidil or finasteride. He is also looking for recommendations on microneedling devices.

The user has been on dutasteride and oral minoxidil for a year with no progress and is considering increasing the dutasteride dose or adding RU58841. Other users suggest consulting a doctor, trying derma needling with topical minoxidil, and note that hair loss treatments can have varying effectiveness.

A 43-year-old shared an 8-month hair regrowth journey using oral minoxidil, dutasteride, topical minoxidil, ketoconazole shampoo, and lifestyle changes. Commenters noted he looked good both with hair and bald.

Finasteride is prescribed at 1mg because it is FDA-approved and proven effective, despite evidence that 0.2mg may similarly reduce DHT. The 1mg dose is more effective for hair growth, and lower doses are less available.

Dutasteride, finasteride, and minoxidil are considered the top hair loss treatments. Other suggested treatments include Nizoral shampoo, tretinoin, pyrilutamide, zinc, biotin, and low light laser therapy, though opinions on their effectiveness vary.

The user is considering switching from finasteride and oral minoxidil to dutasteride and a higher dose of oral minoxidil, taken intermittently, based on their dermatologist's advice. They are unsure about claims that finasteride loses effectiveness after a year and that minoxidil doesn't need daily dosing, and they are seeking community input on these points.

A user shared their 3-year progress using 0.5mg finasteride daily for hair loss, reporting no side effects and significant improvement after 8-10 months. They are considering increasing the dosage or adding minoxidil for further results.

The user is experiencing hair loss despite using Dutasteride and plans to try RU58841, considering adding Oral Minoxidil. They express frustration with diffuse thinning and seek advice on managing hair loss.

The user experienced hair repigmentation and attributes improvements in hair and overall health to a carnivore diet, Boron, and Selenium supplementation. They stopped using finasteride after 20 years, noticed increased testosterone and libido, and observed hair regrowth with RU58841.

Hair loss in your 20s, with treatments like minoxidil, finasteride, dutasteride, and hair transplants discussed. Opinions vary between accepting baldness and pursuing aggressive treatments.

The user experienced significant hair regrowth after starting oral minoxidil (2.5mg) and dutasteride (0.5mg) daily, and is considering resuming microneedling at home with a dermapen. They are concerned about potential risks of microneedling, such as scarring, and are seeking advice on needle length and frequency.

The user is considering hair restoration options after experiencing side effects from Minoxidil and avoiding Finasteride due to concerns about side effects. They are contemplating trying Finasteride or Dutasteride and possibly undergoing a hair transplant.

A user shared their successful hair regrowth journey using finasteride for four years, initially also using Rogaine. They experienced significant improvement, regrowing their hairline and crown, and noted being a hyper responder to the treatment.

A 21-year-old male experiencing hair thinning started using Minoxidil, which stopped his shedding and led to the growth of vellus hairs on his temples. He is considering whether to add finasteride to his routine, which currently includes Minoxidil, derma rolling, ketoconazole shampoo, vitamin D3, zinc, and a rosemary and fenugreek lotion.

The user experienced worsening hair loss despite using finasteride and topical minoxidil, and is considering switching to dutasteride and oral minoxidil. They also tried microneedling and tretinoin with minoxidil, and are exploring Sulfogenz topical minoxidil.

Pelage is developing a topical hair follicle stem cell therapy, PP405, for non-scarring alopecias like androgenetic alopecia, with Phase III trials planned and a potential market launch by 2027. The treatment may not require continuous use after initial regrowth.